Immediate Impact

5 from Science/Nature 66 standout
Sub-graph 1 of 24

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
2 intermediate papers

Works of Chandra Nath Roy being referenced

Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
2019
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
2019

Author Peers

Author Last Decade Papers Cites
Chandra Nath Roy 112 38 206 192 185 44 716
Tapas Biswas 41 7 48 230 177 43 743
Xiao Zhang 24 4 231 179 80 34 767
Xianzhi Yang 37 110 142 178 36 724
Yoshitaka Shimizu 63 95 67 319 27 739
Wenxian Chen 207 125 81 112 56 735
Jingjing Yan 47 2 50 60 207 39 602
Birgit Vogt 59 75 96 193 33 614
Xuesong Wen 27 179 59 200 37 720
Laure Petit 108 164 62 176 16 702
Liyun Chen 28 272 94 166 46 768

All Works

Loading papers...

Rankless by CCL
2026